Wisconsin Assembly Bill AB176

Wisconsin 2023-2024 Regular Session

• Introduced: 4/14/23
• Refer: 4/14/23
• Report Pass: 6/14/23
• Refer: 6/14/23
• Engrossed: 6/21/23
• Refer: 6/23/23
• Failed: 4/15/24

Caption

Permitting pharmacists to prescribe certain contraceptives, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, granting rule-making authority, and providing a penalty. (FE)

Impact

The bill impacts state laws related to the prescribing rights of pharmacists and presents a significant shift towards integrating pharmacists into the healthcare delivery system at a more advanced level. It requires the Pharmacy Examining Board to develop standard procedures and mandates additional screenings for patients, including blood pressure measurements, aiming to preclude contraindicated uses and enhance overall patient safety. Moreover, the legislation ensures that contraceptives prescribed under this bill are covered and reimbursed under the Medical Assistance program, promoting health care equity for individuals with limited financial resources.

Summary

Assembly Bill 176 (AB176) seeks to empower pharmacists in Wisconsin by permitting them to prescribe and dispense certain hormonal contraceptives, specifically hormonal contraceptive patches and self-administered oral hormonal contraceptives. This legislative move aims to enhance accessibility to contraceptive options, especially for those lacking immediate access to healthcare providers. Under AB176, pharmacists must follow specific procedures, including utilizing a self-assessment questionnaire based on guidelines from the American Congress of Obstetricians and Gynecologists, prior to issuing any prescriptions. Such measures are intended to ensure patient safety and informed decision-making regarding contraceptive options.

Contention

Debate regarding AB176 might arise from differing viewpoints on pharmacists' roles versus those of traditional healthcare providers. Advocates might argue that this bill offers essential reproductive health care options, particularly in rural areas where healthcare access is limited. Conversely, opponents may express concerns regarding the adequacy of pharmacist training in prescribing and the potential for patients to receive care without thorough medical assessments typically conducted by physicians. These discussions signify a broader conversation about healthcare access, provider roles, and patient safety in contraceptive provision.